NLTX Annual Working Capital
$88.07 M
-$47.28 M-34.93%
31 December 2022
Summary:
As of January 29, 2025, NLTX annual working capital is $88.07 million, with the most recent change of -$47.28 million (-34.93%) on December 31, 2022. During the last 3 years, it has fallen by -$50.78 million (-36.57%).NLTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Quarterly Working Capital
$74.68 M
-$4.22 M-5.35%
30 September 2023
Summary:
As of January 29, 2025, NLTX quarterly working capital is $74.68 million, with the most recent change of -$4.22 million (-5.35%) on September 30, 2023. Over the past year, it has dropped by -$23.94 million (-24.27%).NLTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.9% | -24.3% |
| 3 y3 years | -36.6% | -62.0% |
| 5 y5 years | -10.0% | -2.4% |
NLTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -52.8% | -62.0% |
Neoleukin Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $74.68 M(-5.3%) |
| June 2023 | - | $78.90 M(+0.5%) |
| Mar 2023 | - | $78.48 M(-10.9%) |
| Dec 2022 | $88.07 M(-34.9%) | $88.07 M(-10.7%) |
| Sept 2022 | - | $98.62 M(-9.7%) |
| June 2022 | - | $109.21 M(-11.0%) |
| Mar 2022 | - | $122.77 M(-9.3%) |
| Dec 2021 | $135.35 M(-27.5%) | $135.35 M(-8.2%) |
| Sept 2021 | - | $147.50 M(-7.8%) |
| June 2021 | - | $159.91 M(-7.5%) |
| Mar 2021 | - | $172.90 M(-7.4%) |
| Dec 2020 | $186.63 M(+34.4%) | $186.63 M(-5.1%) |
| Sept 2020 | - | $196.70 M(+57.8%) |
| June 2020 | - | $124.68 M(-7.0%) |
| Mar 2020 | - | $134.05 M(-3.5%) |
| Dec 2019 | $138.85 M(+91.4%) | $138.85 M(+113.6%) |
| Sept 2019 | - | $65.02 M(-9.8%) |
| June 2019 | - | $72.05 M(+1.1%) |
| Mar 2019 | - | $71.23 M(-1.8%) |
| Dec 2018 | $72.54 M | $72.54 M(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $76.54 M(-14.8%) |
| June 2018 | - | $89.89 M(+5.9%) |
| Mar 2018 | - | $84.87 M(-13.3%) |
| Dec 2017 | $97.87 M(+4.2%) | $97.87 M(-13.8%) |
| Sept 2017 | - | $113.58 M(-8.5%) |
| June 2017 | - | $124.06 M(+6.4%) |
| Mar 2017 | - | $116.61 M(+24.1%) |
| Dec 2016 | $93.97 M(+34.2%) | $93.97 M(-31.9%) |
| Sept 2016 | - | $138.05 M(+133.4%) |
| June 2016 | - | $59.15 M(-7.2%) |
| Mar 2016 | - | $63.76 M(-8.9%) |
| Dec 2015 | $70.00 M(+105.3%) | $70.00 M(-38.6%) |
| Sept 2015 | - | $114.08 M(+342.5%) |
| June 2015 | - | $25.78 M(-14.2%) |
| Mar 2015 | - | $30.05 M(-11.9%) |
| Dec 2014 | $34.10 M(+169.0%) | $34.10 M(-4.7%) |
| Sept 2014 | - | $35.79 M(+6.9%) |
| June 2014 | - | $33.50 M(-39.1%) |
| Mar 2014 | - | $55.01 M(+334.0%) |
| Dec 2013 | $12.68 M(+655.1%) | $12.68 M |
| Dec 2012 | $1.68 M | - |
FAQ
- What is Neoleukin Therapeutics annual working capital?
- What is the all time high annual working capital for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics annual working capital year-on-year change?
- What is Neoleukin Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics quarterly working capital year-on-year change?
What is Neoleukin Therapeutics annual working capital?
The current annual working capital of NLTX is $88.07 M
What is the all time high annual working capital for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual working capital is $186.63 M
What is Neoleukin Therapeutics annual working capital year-on-year change?
Over the past year, NLTX annual working capital has changed by -$47.28 M (-34.93%)
What is Neoleukin Therapeutics quarterly working capital?
The current quarterly working capital of NLTX is $74.68 M
What is the all time high quarterly working capital for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly working capital is $196.70 M
What is Neoleukin Therapeutics quarterly working capital year-on-year change?
Over the past year, NLTX quarterly working capital has changed by -$23.94 M (-24.27%)